These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15889942)

  • 1. An open-label study of amisulpride in the treatment of mania.
    Vieta E; Ros S; Goikolea JM; Benabarre A; Popova E; Comes M; Capapey J; Sánchez-Moreno J
    J Clin Psychiatry; 2005 May; 66(5):575-8. PubMed ID: 15889942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-year follow-up of patients treated with risperidone and topiramate for a manic episode.
    Vieta E; Goikolea JM; Olivares JM; González-Pinto A; Rodriguez A; Colom F; Comes M; Torrent C; Sánchez-Moreno J
    J Clin Psychiatry; 2003 Jul; 64(7):834-9. PubMed ID: 12934986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and continuation risperidone monotherapy in mania.
    Vieta E; Brugué E; Goikolea JM; Sánchez-Moreno J; Reinares M; Comes M; Colom F; Martínez-Arán A; Benabarre A; Torrent C
    Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.
    Treuer T; Oruc L; Loza N; El Saidi MA; Kovacs Z; Akkaya C; Gülseren S; Saylan M; Colman SA; Harrison GA
    Psychiatr Danub; 2007 Dec; 19(4):282-95. PubMed ID: 18000479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.
    Shansis FM; Reche M; Capp E
    J Affect Disord; 2016 Jun; 197():1-7. PubMed ID: 26950019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
    J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of risperidone in bipolar II: an open 6-month study.
    Vieta E; Gastó C; Colom F; Reinares M; Martínez-Arán A; Benabarre A; Akiskal HS
    J Affect Disord; 2001 Dec; 67(1-3):213-9. PubMed ID: 11869771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in Korea.
    Woo YS; Bahk WM; Jon DI; Chung SK; Lee SY; Ahn YM; Pae CU; Cho HS; Kim JG; Hwang TY; Lee HS; Min KJ; Lee KU; Yoon BH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):28-37. PubMed ID: 19895394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.
    Herrera-Estrella M; Apiquian R; Fresan A; Sanchez-Torres I
    BMC Psychiatry; 2005 May; 5():22. PubMed ID: 15869707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
    Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K;
    Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial.
    Sajatovic M; Coconcea N; Ignacio RV; Blow FC; Hays RW; Cassidy KA; Meyer WJ
    J Clin Psychiatry; 2008 Jan; 69(1):41-6. PubMed ID: 18312036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.